Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

BioNTech

Biotech & Life Sciences · Mainz, Germany · Founded 2008 · IPO 2019 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$8.57B
Market cap · Apr/2026
Revenue
$3.16B
Latest reported FY

Investors

17 investors on BioNTech's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 3 investors entered at this stage
ATHOS Venture
MIG Capital
Santo Holding
Series A 6 investors entered at this stage
Fidelity Investments
Eli Lilly
Janus Henderson Investors
Invus
Redmile Group
Janus Henderson
Series B+ 8 investors entered at this stage
Sanofi
Jebsen Capital
Genentech
Temasek
Platinum Asset Management
Mirae Asset Venture Investment
Bayer
Johannes Gutenberg University Mainz

Global footprint

Where BioNTech has talent and traffic

AI talent share
1.5% of workforce is AI talent
(76 of 5,107 staff)
Core AI240.47%
Other AI521.02%
Non-AI workforce5,03198.51%
Web traffic by country
130K monthly visits
across markets
🇩🇪 Germany32.4%
🇺🇸 United States18.2%
🇬🇧 United Kingdom10%
🇮🇳 India7.8%
🇦🇺 Australia3.8%
Top 5 markets shown

Patent intelligence

$780M patent portfolio · 457 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$780M
9.1% of market cap · 2.8× the top peer argenx ($275M)
457 active patent families
Where BioNTech innovates Molecular biologyPharmaceutical drugCancer researchTGE VACCINECarcinosis
Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

BioNTech on the five Patsnap quality dimensions

BioNTech in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where BioNTech concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across BioNTech and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See BioNTech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo